Proline metabolic reprogramming modulates cardiac remodeling induced by pressure overload in the heart.
Qingbo LvDuanBin LiLiding ZhaoPengcheng YuYecheng TaoQiongjun ZhuYao WangMeihui WangGuo-Sheng FuMin ShangWenbin ZhangPublished in: Science advances (2024)
Metabolic reprogramming is critical in the onset of pressure overload-induced cardiac remodeling. Our study reveals that proline dehydrogenase (PRODH), the key enzyme in proline metabolism, reprograms cardiomyocyte metabolism to protect against cardiac remodeling. We induced cardiac remodeling using transverse aortic constriction (TAC) in both cardiac-specific PRODH knockout and overexpression mice. Our results indicate that PRODH expression is suppressed after TAC. Cardiac-specific PRODH knockout mice exhibited worsened cardiac dysfunction, while mice with PRODH overexpression demonstrated a protective effect. In addition, we simulated cardiomyocyte hypertrophy in vitro using neonatal rat ventricular myocytes treated with phenylephrine. Through RNA sequencing, metabolomics, and metabolic flux analysis, we elucidated that PRODH overexpression in cardiomyocytes redirects proline catabolism to replenish tricarboxylic acid cycle intermediates, enhance energy production, and restore glutathione redox balance. Our findings suggest PRODH as a modulator of cardiac bioenergetics and redox homeostasis during cardiac remodeling induced by pressure overload. This highlights the potential of PRODH as a therapeutic target for cardiac remodeling.
Keyphrases
- left ventricular
- heart failure
- cell proliferation
- high glucose
- oxidative stress
- type diabetes
- poor prognosis
- mass spectrometry
- adipose tissue
- spinal cord injury
- insulin resistance
- single cell
- spinal cord
- transcription factor
- drug induced
- high fat diet induced
- human health
- atrial fibrillation
- diabetic rats
- binding protein